Erratum: Total synthesis and structural confirmation of chlorodysinosin A (Journal of the American Chemical Society (2006) 128 (10491-10495))

Journal of the American Chemical Society

Volumn 128, Issue 35, 2006, Pages 11727-11728

  Hanessian, Stephen ^a   Del Valle, Juan R ^a   Xue, Yafeng ^a   Blomberg, Niklas ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; ERROR;

EID: 33748355617     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja069971q     Document Type: Erratum

References (108)

1. For recent reviews on cyanobacterial metabolites, see: (a) Burja, A. M.; Banaigs, B.; Abou-Mansour, E.; Burgess, L. G.; Wright, P. C. Tetrahedron 2001, 57, 9347.
2. (b) Leusch, H.; Harrigan, G. G.; Goetz, G.; Horgen, F. D. Curr. Med. Chem. 2002, 9, 179.
3. (c) Shiori, T.; Hamada, Y. Synlett 2001, 184.
4. (d) Lewis, J. R. Nat. Prod. Rep. 1998, 417.
5. (e) Namikoshi, M.; Rinehart, K. L. J. Indust. Microbiol. 1996, 17, 373.
6. (f) Rinehart, K. L.; Namikoshi, M.; Choi, B. W. J. Appl. Phycol. 1994, 6, 159.
7. (a) Colman, R. W.; Clowes, A. W.; George, J. N.; Hirsch, J. L.; Marder, J. V. In Overview of Homeostasis, 4th ed.;
8. Colman, R. W., Hirsh, J. L., Marder, J. V., Clowes, A. W., George, J. N., Eds.; Hemostasis and Thrombosis. Basic Principles and Clinical Practice; Lippincott Williams & Wilkins: Philadelphia, 2001; p 3.
9. (b) Dahlbäck, B. Lancet 2000, 355, 1627.
10. (c) Steinmetz, T.; Hauptman, J.; Stürzbecher, J. Exp. Opin. Invest Drugs 2000, 10, 845.
11. (d) Kimball, S. D. Blood Coagul. Fibrinol. 1995, 6, 511.
12. For selected reviews on thrombin inhibitors, see: (a) Sanderson, P. E.; Nayler-Olson, A. M. Curr. Med. Chem. 1998, 5, 289.
13. (b) Ripka, W. E. Curr. Opin. Chem. Biol. 1997, 1, 242.
14. (c) Pfau, R. Curr. Opin. Drug Discovery 2003, 6, 437.
15. (a) Hanessian, S.; Therrien, E.; van Otterlo, W. A. L.; Bayrakdarian, M. A.; Nilsson, I.; Fjellström, O.; Xue, Y. Bioorg. Med. Chem. Lett. 2006, 16, 1032.
16. (b) Hanessian, S.; Tremblay, M.; Marzi, M.; Del Valle, J. R. J. Org. Chem. 2005, 70, 5070.
17. (c) Hanessian, S.; Sailes, H.; Therrien, E. Tetrahedron 2003, 59, 7047.
18. (d) Hanessian, S.; Balaux, E.; Musil, D.; Olsson, L.-L.; Nilsson, I. Bioorg. Med. Chem. Lett. 2000, 10, 243.
19. (e) Hanessian, S.; Therrien, E.; Granberg, K.; Nilsson, I. Bioorg. Med. Chem. Lett. 2000, 12, 2907.
20. (a) Liu, Z.; Ranier, J. D. Org. Lett. 2006, 8, 459.
21. (b) Nie, X.; Wang, G. J. Org. Chem. 2005, 70, 8687.
22. (c) Fukuta, Y.; Ohshima, T.; Gnanadesikan, V.; Shibuguchi, T.; Nemoto, T.; Kisugi, T.; Okino, T.; Shibasaki, M. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 5433.
23. (d) Toyooka, N.; Nakazawa, A.; Himiyama, T.; Nemoto, H. Heterocycles 2003, 59, 75.
24. (e) Toyooka, N.; Okumura, M.; Himiyama, T.; Nakazawa, A.; Nemoto, H. Synlett 2003, 55.
25. (f) Valls, N.; Vallribera, M.; Font-Bardìa, M.; Solans, X.; Bonjoch, J. Tetrahedron: Asymmetry 2003, 14, 1241.
26. (g) Radau, G.; Stürzebecher, J. Pharmazie 2002, 57, 11.
27. (h) Radau, G.; Rauh, D. Bioorg. Med. Chem. Lett. 2000, 10, 779.
28. (i) Bonjoch, J.; Catena, J.; Isábal, E.; López-Canet, M.; Valls, N. Tetrahedron: Asymmetry 1996, 7, 1899.
29. (a) Aeruginosin 298A: Murakami, M.; Okita, Y.; Matsuda, H.; Okino, T.; Yamaguchi, K. Tetrahedron Lett. 1994, 35, 3129.
30. (b) Aeruginosins 98A and 98B: Murakami, M.; Ishida, K.; Okino, T.; Okita, Y.; Matsuda, H.; Yamaguchi, K. Tetrahedron Lett. 1995, 36, 2785.
31. (c) Aeruginosins 102A and 102B: Matsuda, H.; Okino, T.; Murakami, M.; Yamaguchi, K. Tetrahedron 1996, 52, 14501.
32. (d) Aeruginosins 205A and 205B: Shin, H. J.; Matsuda, H.; Murakami, M.; Yamaguchi, K. J. Org. Chem. 1997, 62, 1810.
33. (e) Oscillarin: Engh, R.; Konetschny-Rapp, S.; Krell, H.-W.; Martin, U.; Tsaklakidis, C. PCT WO97/21725; Chem Abst. 1997, 127, 122002.
34. (f) Aeruginosin 103A: Kodani, S.; Ishida, K.; Murakami, M. J. Nat. Prod. 1998, 61, 1046.
35. (g) Microcin SF608: Banker, R.; Carmelli, S. Tetrahedron 1999, 55, 10835.
36. (h) Aeruginosins 98C, 101, 298B, 89A, and 89B: Ishida, K.; Okita, Y.; Matsuda, H.; Okino, T.; Murakami, M. Tetrahedron 1999, 55, 10971.
37. (i) Aeruginosin EI461: Pluotno, A.; Shoshan, M.; Carmelli, S. J. Nat. Prod. 2002, 65, 973.
38. (a) Dysinosin A: Carroll, A. R.; Pierens, G.; Fechner, G.; de Almeida Leone, P.; Ngo, A.; Simpson, M.; Hooper, J. N. A.; Boström, S.-L.; Musil, D.; Quinn, R. J. J. Am. Chem. Soc. 2002, 124, 13340.
39. (b) Chlorodysinosin A: Goetz, G. H.; Harrigan, G. G.; Likos, J. J.; Kasten, T. P. PCT WO03/051831; Chem. Abst. 2003, 139, 47155.
40. (c) Dysinosins B, C, and D: Carroll, A. R.; Buchanan, M. S.; Edser, A.; Hyde, E.; Simpson, M.; Quinn, R. J. J. Nat. Prod. 2004, 67, 1291.
41. Total syntheses of aeruginosin 298A: (a) Methot, J.-L.; Wipf, P. Org. Lett. 2000, 2, 4213.
42. (b) Valls, N.; López-Canet, M.; Vallribera, M.; Bonjoch, J. J. Am. Chem. Soc. 2000, 122, 11248.
43. (c) Ohshima, T.; Gnanadesikan, V.; Shibuguchi, T.; Fukuta, Y.; Nemoto, T.; Shibasaki, M. J. Am. Chem. Soc. 2003, 125, 11206.
44. (d) For the total synthesis of aeruginosins 298B, see: Valls, N.; López-Canet, M.; Vallribera, M.; Bonjoch, J. Chem.-Eur. J. 2001, 7, 3446.
45. Aeruginosin EI461: Valls, N.; Vallribera, M.; Carmeli, S.; Bonjoch, J. Org. Lett. 2003, 5, 447.
46. Microcin SF608: Valls, N.; Vallribera, M.; López-Canet, M.; Bonjoch, J. J. Org. Chem. 2002, 67, 4945.
47. Oscillarin: Hanessian, S.; Tremblay, M.; Petersen, J. F. W. J. Am. Chem. Soc. 2004, 126, 6064.
48. Dysinosin A: Hanessian, S.; Margarita, R.; Hall, A.; Johnstone, S.; Tremblay, M.; Parlanti, L. J. Am. Chem. Soc. 2002, 124, 13342.
49. The originally proposed structures of aeruginosins 298A, 298B, EI461 and oscillarin have been revised through synthesis. The proposed structures of aeruginosins 205A and 205B have been called into question through synthesis and NMR analysis of the putative hydroindole core residue (see ref 14a).
50. (a) For a stereoselective synthesis of diastereomeric 3-chloroleucines, see: Valls, N.; Borregán, M.; Bonjoch, J. Tetrahedron Lett. 2006, 47, 3701.
51. (b) A nondiastereoselective synthesis of racemic 3-chloroleucine has been reported: Hayashi, K.; Skinner, C. G.; Shive, W. J. Org. Chem. 1961, 26, 1167.
52. (a) For an insightful report on the possible link between metabolites from Oscillatoria cyanobacteria and Lamellodysidea marine sponges, see: Ridley, C. P.; Bergquist, P. R.; Harper, M. K.; Faulkner, D. J.; Hooper, J. N. A.; Haygood, M. G. Chem. Biol. 2005, 12, 397.
53. (b) Vaillancourt, F.; Yeh, E.; Vosburg, D. A.; Garneau-Tsodikova, S.; Walsh, C. T. Chem. Rev. 2006, ASAP.
54. (c) van Peé, K.-H. Annu. Rev. Microbiol. 1996, 50, 375.
55. (d) Gribble, G. J. Nat. Prod. 1992, 55, 1353.
56. (e) Bewley, C. A.; Faulkner, D. J. Angew. Chem., Int. Ed. 1998, 37, 2162.
57. (f) Fusetani, N.; Matsunaga, S. Chem. Rev. 1993, 93, 1783.
58. (g) Fukuchi, N.; Isogai, A.; Yamashita, S.; Suyama, K.; Takemoto, J. Y.; Suzuki, A. Tetrahedron Lett. 1990, 31, 1589.
59. (h) Moore, R. E.; Bornemann, V.; Niemczura, W. P.; Gregson, J. M.; Chen, J.-L.; Norton, T. R.; Patterson, G. M. L.; Helms, G. L. J. Am. Chem. Soc. 1989, 111, 6128.
60. (a) Morita, H.; Nagashima, S.; Koichi, T.; Itokawa, H. Chem. Pharm. Bull. 1993, 41, 992.
61. For examples of other peptide natural products featuring β-chlorinated proline residues, see: (b) Marumo, S.; Sumiki, Y. Nippon Nogei Kagaku Kaishi 1955, 29, 395.
62. (c) Ghosh, A. C.; Ramgopal, M. J. Heterocycl. Chem. 1980, 17, 1809.
63. (d) Kosemura, S.; Ogawa, T.; Kazuo, T. Tetrahedron Lett. 1993, 34, 1291.
64. (a) Kuroda, Y.; Okuhara, M.; Goto, T.; Yamashita, M.; Iguchi, E.; Kohsaka, M.; Aoki, H.; Imanaka, H. J. Antibiot. 1980, 33, 259.
65. (b) Yasuda, N.; Sakane, K. J. Antibiot. 1991, 44, 801.
66. Ohtsu, Y.; Sasamura, H.; Tsurumi, Y.; Yoshimura, S.; Shigematsu, N.; Takase, S.; Hashimoto, M.; Shibata, T.; Hino, M.; Fujii, T. J. Antibiot. 2003, 56, 682.
67. For reviews on the synthesis of fluorinated amino acids, see: (a) Kukhar, V. P.; Soloshonok, V. A. Fluorine Containing Amino Acids: Synthesis and Properties; Wiley: New York, 1995.
68. (b) Qiu, X.-L.; Meng, W.-D.; Qing, F.-L. Tetrahedron 2004, 60, 6711.
69. (c) Sutherland, A.; Willis, C. L. Nat. Prod. Rep. 2000, 17, 621.
70. For relevant examples of the synthesis of other halogenated amino acids, see: (d) Meyer, F.; Laaziri, A.; Papini, A. M.; Uziel, J.; Jugé, S. Tetrahedron: Asymmetry 2003, 14, 2229.
71. (e) Pansare, S. V.; Vederas, J. C. J. Org. Chem. 1989, 54, 2311.
72. (f) Chuang, T.-H.; Sharpless, K. B. Org. Lett. 2000, 2, 3555.
73. (g) Choi, D.; Kohn, H. Tetrahedron Lett. 1995, 36, 7011.
74. (h) Righi, G.; D'Achille, R. Tetrahedron Lett. 1996, 37, 6893.
75. (i) Schumacher, K. K.; Jiang, J.; Joullié, M. M. Tetrahedron: Asymmetry 1998, 9, 47.
76. (j) Laszlo, S. E.; Willard, P. G. J. Am. Chem. Soc. 1985, 107, 199.
77. (a) Srinivasan, A.; Stephenson, R. W.; Olsen, R. K. J. Org. Chem. 1977, 41, 2253.
78. (b) Dunn, M. J.; Gomez, S.; Jackson, R. F. W. J. Chem. Soc., Perkin Trans. 1 1995, 1639.
79. (c) Gelb, M. H.; Lin, Y.; Pickard, M. A.; Song, Y.; Vederas, J. C. J. Am. Chem. Soc. 1990, 112, 4932.
80. (d) Murkin, A. S.; Tanner, M. E. J. Org. Chem. 2002, 67, 8389.
81. 2/NaI as halide sources, see: (a) Righi, G.; Franchini, T.; Bonini, C. Tetrahedron Lett. 1998, 39, 2385.
82. For recent reviews on halogenolysis of activated aziridines, see: (b) Righi, G.; Bonini, C. Recent Res. Org. Chem. 1999, 343.
83. (c) McCoull, W.; Davis, F. A. Synthesis 2000, 1347.
84. (d) Hu, X. E. Tetrahedron 2004, 60, 2701.
85. Caldwell, C. G.; Bondy, S. S. Synthesis 1990, 34.
86. Sabitha, G.; Babu, R. S.; Rajkumar, M.; Reddy, Ch. S.; Yadav, J. S. Tetrahedron Lett. 2001, 42, 3955.
87. Sun, P.; Weinreb, S. J. Org. Chem. 1997, 62, 8604
88. Gontcharov, A. V.; Liu, H.; Sharpless, K. B. Org. Lett. 1999, 1, 783.
89. Zhao, M.; Li, J.; Song, Z.; Desmond, R.; Tschaen, D. M.; Grabowski, E. J. J.; Reider, P. J. Tetrahedron Lett. 1998, 39, 5323.
90. For a review of peptide coupling methods as applied to the synthesis of complex natural products, see: Humphrey, J. M.; Chamberlin, A. R. Chem. Rev. 1997, 97, 2243.
91. (a) Li, H.-T.; Jiang, X.-H.; Ye, Y.-H.; Fan, C.-X.; Romoff, T.; Goodman, M. Org. Lett. 1999, 1, 91.
92. (b) Fan, C.-X.; Hao, X.-L.; Ye, Y.-H. Synth. Commun. 1996, 26, 1455.
93. For discussions on the effectiveness of DEPBT in difficult coupling reactions en route to complex natural products, see: (c) Jiang, W.; Wanner, J.; Lee, R. J.; Bounaud, P.-Y.; Boger, D. L. J. Am. Chem. Soc. 2003, 125, 1877.
94. (d) Ye, Y.-H.; Li, H.-T.; Jiang, X.-H. Biopolymers 2005, 80, 172.
95. See: Hanessian, S.; Kagotani, M. Carbohydr. Res. 1990, 202, 67 and referenced cited therein.
96. Ohno, M.; Otsuka, M. Org. React. 1989, 37, 1.
97. (a) Reddy, L. R.; Fournier, J.-F.; Reddy, B. V. S.; Corey, E. J. J. Am. Chem. Soc. 2005, 125, 8974.
98. (b) Reddy, B. V. S.; Rajender, Reddy, L. J.; Corey, E. J. Tetrahedron Lett. 2005, 46, 4589.
99. For a recent application, see: (a) Nicolaou, K. C.; Estrada, A. A.; Zak, M.; Lee, S. H.; Safina, B. S. Angew. Chem., Int. Ed. 2005, 44, 1378.
100. See also: (b) David, S.; Hanessian, S. Tetrahedron 1985, 4, 643.
101. (a) Lubineau, A.; Lemoine, R. Tetrahedron Lett. 1994, 35, 8795.
102. (b) Sanders, W. J.; Manning, D. D.; Koeller, K. M.; Keissling, L. L. Tetrahedron 1997, 53, 16391.
103. Nilsson, T.; Sjoling-Ericksson, A.; Deinum, J. J. Enzyme Inhibition 1998, 13, 11.
104. Data for cocrystal structure of 2 bound to thrombin has been registered with the protein data bank under PDB ID: 2GDE.
105. (a) Recacha, R.; Costanzo, M. J.; Maryanoff, B. E.; Carson, M.; DeLucas, L.; Chattopadhyay, D. Acta Crystallogr. 2000, D56, 1395.
106. (b) Malikowski, M. G.; Martin, P. D.; Guzik, J. C.; Edwards, B. F. P. Protein Sci. 1997, 6, 1438.
107. 1 angles and energy minimized conformations of 1 and 2.
108. Ward, W. H.; Holdgate, G. A. Prog. Med. Chem. 2001, 38, 309.